| Breakdown | TTM | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 | Feb 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 298.25B | 293.11B | 275.60B | 242.55B | 201.58B | 183.87B |
| Gross Profit | 161.88B | 149.10B | 142.61B | 124.22B | 104.28B | 93.13B |
| EBITDA | 25.74B | 27.00B | 28.31B | 20.57B | 13.67B | 7.21B |
| Net Income | 8.65B | 9.61B | 13.51B | 7.54B | 4.92B | -693.00M |
Balance Sheet | ||||||
| Total Assets | 139.41B | 133.11B | 127.92B | 111.39B | 97.96B | 95.62B |
| Cash, Cash Equivalents and Short-Term Investments | 22.43B | 21.14B | 23.37B | 16.38B | 16.98B | 24.18B |
| Total Debt | 4.73B | 8.96B | 8.95B | 8.18B | 5.01B | 3.64B |
| Total Liabilities | 58.96B | 55.91B | 56.33B | 50.63B | 42.99B | 44.92B |
| Stockholders Equity | 80.08B | 77.10B | 70.14B | 59.41B | 53.96B | 50.70B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 13.85B | 16.55B | 6.47B | -292.00M | 8.13B |
| Operating Cash Flow | 0.00 | 21.37B | 22.22B | 13.46B | 3.50B | 11.93B |
| Investing Cash Flow | 0.00 | -16.97B | -9.92B | -9.96B | -7.78B | -7.37B |
| Financing Cash Flow | 0.00 | -7.11B | -5.58B | -4.40B | -3.25B | -6.84B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥51.33B | 7.26 | 18.28% | 6.12% | -6.22% | 679.61% | |
66 Neutral | ¥137.07B | 17.53 | 2.80% | 3.38% | >-0.01% | -49.83% | |
66 Neutral | ¥37.54B | 13.45 | ― | 5.23% | ― | ― | |
64 Neutral | ¥128.59B | 9.43 | 11.70% | 3.59% | 3.96% | -36.24% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
59 Neutral | ¥207.62B | 39.72 | 5.31% | 2.29% | -6.04% | 146.54% | |
57 Neutral | ¥15.75B | -14.15 | ― | ― | 4.15% | -289.87% |